BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 3979271)

  • 1. [Serologic analysis of HBc antigen in patients with HBs-antigen carrier state].
    Möller B; Hopf U; Shirpai M; Lobeck H
    Dtsch Med Wochenschr; 1985 Mar; 110(11):407-11. PubMed ID: 3979271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage.
    Alberti A; Diana S; Scullard GH; Eddleston WF; Williams R
    Gastroenterology; 1978 Nov; 75(5):869-74. PubMed ID: 700329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification and infectiousness of chronic hepatitis B, defined by the Dane particle in the blood and virus components in the liver].
    Gudat F; Bianchi L; Stalder GA; Schmid M
    Schweiz Med Wochenschr; 1976 Jun; 106(24):812-24. PubMed ID: 792997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
    Hess G; Wagner J; Arnold W; Purcell RH; Meyer zum Büschenfelde KH
    Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The "e" antigen system in HBs antigen carriers (author's transl)].
    Schnell P; Courouce AM; Opolon P; Darnis F
    Nouv Presse Med; 1978 Oct; 7(35):3105-8. PubMed ID: 103075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers.
    Lazizi Y; Dubreuil P; Pillot J
    Hepatology; 1993 Jun; 17(6):966-70. PubMed ID: 8514269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
    Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioclinical significance of the specificities of the hepatitis B HBe system].
    Rioche M
    Pathol Biol (Paris); 1985 Dec; 33(10):945-50. PubMed ID: 2419824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
    Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
    Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
    Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
    Zoulim F; Capel F; Berthillon P; Trépo C; Petit MA
    Gastroenterol Clin Biol; 1995 Dec; 19(12):970-5. PubMed ID: 8729407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antinuclear antibody (anti-HBc) and liver pathology in acute and chronic virus B hepatitis].
    Dentico P; Pastore G; Buongiorno R; Angarano G; Lapedota E; Schiraldi O
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1141-6. PubMed ID: 317942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B core antigen and antibody.
    Hoofnagle JH; Gerety RJ; Barker LF
    Dev Biol Stand; 1975; 30():175-85. PubMed ID: 1204955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.